Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 12:5:37.
doi: 10.3389/fcvm.2018.00037. eCollection 2018.

"Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention"

Alec Vahanian  1 , Eric Brochet  1 , Jean-Michel Juliard  1
Affiliations

"Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention"

Alec Vahanian et al. Front Cardiovasc Med. .

Abstract

Tricuspid regurgitation (TR) is an important clinical problem because it is frequent and carries a poor prognosis when it is left uncorrected. However, there is still a lack of awareness of tricuspid disease in the medical community. The indications for evaluation and surgical interventions in patients with TR were recently updated in the ESC/EACTS guidelines. Transcatheter tricuspid valve intervention (TTVI), almost exclusively valve repair, is at an early stage of development as only a few hundreds of patients have been treated. The first-in-man valve implantation was very recently performed. The recent ESC/EACTS Guidelines state that "The potential role of transcatheter tricuspid valve treatment in high-risk patients needs to be determined". We shall review here which lessons of interest for TTVI can be learned from the Guidelines as regards evaluation and indications for surgery and try to imagine what could be the place of TTVI in the Guidelines in the future.

Keywords: TAVI; TTVI; guidelines; transcatheter valve intervention; tricuspid regurgitation; tricuspid surgery.

PubMed Disclaimer

References

    1. Arsalan M, Walther T, Smith RL, Grayburn PA, Taramasso M, Vanermen H. Tricuspid regurgitation diagnosis and treatment. Eur Heart J (2017) 38(9):634–8. 10.1093/eurheartj/ehv487 - DOI - PubMed
    1. Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol (2012) 59(8):703–10. 10.1016/j.jacc.2011.09.069 - DOI - PubMed
    1. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol (2004) 43(3):405–9. 10.1016/j.jacc.2003.09.036 - DOI - PubMed
    1. Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging (2014) 7(12):1185–94. 10.1016/j.jcmg.2014.07.018 - DOI - PubMed
    1. Dreyfus GD, Martin RP, Chan KM, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation: a need to revise our understanding. J Am Coll Cardiol (2015) 65(21):2331–6. 10.1016/j.jacc.2015.04.011 - DOI - PubMed

LinkOut - more resources